Published in Oncogene on June 03, 1999
MET as a target for treatment of chest tumors. Lung Cancer (2008) 1.29
Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells. Br J Cancer (2009) 1.18
Epidermal growth factor receptor plays a significant role in hepatocyte growth factor mediated biological responses in mammary epithelial cells. Cancer Biol Ther (2007) 1.14
MET pathway as a therapeutic target. J Thorac Oncol (2009) 1.06
Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis. Mol Cell Biol (2000) 0.98
Transforming growth factor-beta1 effects on endothelial monolayer permeability involve focal adhesion kinase/Src. Am J Respir Cell Mol Biol (2007) 0.94
Hepatocyte growth factor regulates cyclooxygenase-2 expression via beta-catenin, Akt, and p42/p44 MAPK in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol (2008) 0.93
Transforming growth factor-β1 selectively inhibits hepatocyte growth factor expression via a micro-RNA-199-dependent posttranscriptional mechanism. Mol Biol Cell (2013) 0.91
SF/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma. World J Gastroenterol (2001) 0.91
Serotonin induces pulmonary artery smooth muscle cell migration. Biochem Pharmacol (2006) 0.90
Retinoic acid inhibits airway smooth muscle cell migration. Am J Respir Cell Mol Biol (2006) 0.88
Hepatocyte growth factor in lung repair and pulmonary fibrosis. Acta Pharmacol Sin (2010) 0.87
Hepatocyte growth factor inhibits apoptosis by the profibrotic factor angiotensin II via extracellular signal-regulated kinase 1/2 in endothelial cells and tissue explants. Mol Biol Cell (2010) 0.84
Gab1 mediates hepatocyte growth factor-stimulated mitogenicity and morphogenesis in multipotent myeloid cells. J Cell Biochem (2010) 0.83
Myogenic cell response to muscle contraction with short electrical stimulation. J Phys Ther Sci (2015) 0.76
Hepatocyte Growth Factor Mediates Enhanced Wound Healing Responses and Resistance to Transforming Growth Factor-β₁-Driven Myofibroblast Differentiation in Oral Mucosal Fibroblasts. Int J Mol Sci (2017) 0.75
A tandem repeat of a fragment of Listeria monocytogenes internalin B protein induces cell survival and proliferation. Am J Physiol Lung Cell Mol Physiol (2010) 0.75
Transcriptional gene expression profiles of HGF/SF-met signaling pathway in colorectal carcinoma. World J Gastroenterol (2003) 0.75
Stromal cues regulate the pancreatic cancer epigenome and metabolome. Proc Natl Acad Sci U S A (2017) 0.75
Expression array analysis of the hepatocyte growth factor invasive program. Clin Exp Metastasis (2015) 0.75
Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci U S A (1992) 4.50
PDGF induction of tyrosine phosphorylation of GTPase activating protein. Nature (1989) 4.36
Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science (1991) 3.69
Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem (1992) 2.93
A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci U S A (1991) 2.93
Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science (1995) 2.83
Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J Biol Chem (2000) 2.24
Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling. J Biol Chem (1999) 2.12
Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF-dependent mitogenic signals. EMBO J (1993) 1.92
Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: potential role of glycogen synthase kinase-3beta. FASEB J (2002) 1.87
A protein-binding domain, EH, identified in the receptor tyrosine kinase substrate Eps15 and conserved in evolution. Proc Natl Acad Sci U S A (1995) 1.87
Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial. Infect Immun (2001) 1.81
Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim Biophys Acta (1993) 1.76
Expression cloning of a human dual-specificity phosphatase. Proc Natl Acad Sci U S A (1992) 1.59
Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev (1998) 1.58
c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res (1998) 1.54
Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res (1991) 1.52
Identification of a competitive HGF antagonist encoded by an alternative transcript. Science (1991) 1.44
A novel dual specificity phosphatase induced by serum stimulation and heat shock. J Biol Chem (1994) 1.38
The role of autophosphorylation in modulation of erbB-2 transforming function. New Biol (1990) 1.33
Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells. Proc Natl Acad Sci U S A (1994) 1.25
Keratinocyte growth factor. Cell Biol Int (1995) 1.20
Identification and biochemical characterization of novel putative substrates for the epidermal growth factor receptor kinase. J Biol Chem (1992) 1.13
Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF/scatter factor variant with partial agonist/antagonist activity. J Biol Chem (1996) 1.13
Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling. J Biol Chem (2001) 1.10
Expression of biologically active recombinant keratinocyte growth factor. Structure/function analysis of amino-terminal truncation mutants. J Biol Chem (1993) 1.08
Biosynthesis of the 67 kDa high affinity laminin receptor. Biochem Biophys Res Commun (1991) 1.07
Identification of tyrosine 187 as a protein kinase C-delta phosphorylation site. J Biol Chem (1996) 1.06
Conformational changes in the alpha- and beta-subunits of the insulin receptor identified by anti-peptide antibodies. J Biol Chem (1989) 1.03
Potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion and branching morphogenesis by antagonists of Grb2 Src homology 2 domain interactions. J Biol Chem (2001) 1.03
Keratinocyte growth factor. A fibroblast growth factor family member with unusual target cell specificity. Ann N Y Acad Sci (1991) 1.01
Microtubule dynamic turnover is suppressed during polarization and stimulated in hepatocyte growth factor scattered Madin-Darby canine kidney epithelial cells. Cell Motil Cytoskeleton (1996) 0.99
Differential effects of hepatocyte growth factor isoforms on epithelial and endothelial tubulogenesis. Cell Growth Differ (1998) 0.98
The juxtamembrane regions of the epidermal growth factor receptor and gp185erbB-2 determine the specificity of signal transduction. Mol Cell Biol (1991) 0.98
Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis. Mol Cell Biol (2000) 0.98
Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli. Biochem J (1997) 0.96
Transformation of NIH3T3 fibroblasts by an expression vector for the human epidermal growth factor precursor. Oncogene (1990) 0.96
Identification and dynamics of a heparin-binding site in hepatocyte growth factor. Biochemistry (1999) 0.96
Inverse modulation of steady-state messenger RNA levels of two non-integrin laminin-binding proteins in human colon carcinoma. J Natl Cancer Inst (1992) 0.95
Identification of serine 643 of protein kinase C-delta as an important autophosphorylation site for its enzymatic activity. J Biol Chem (1997) 0.94
Keratinocyte growth factor as a cytokine that mediates mesenchymal-epithelial interaction. EXS (1995) 0.93
Distinct expression patterns and transforming properties of multiple isoforms of Ost, an exchange factor for RhoA and Cdc42. Oncogene (1999) 0.92
The solution structure of the N-terminal domain of hepatocyte growth factor reveals a potential heparin-binding site. Structure (1998) 0.92
High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains. Proc Natl Acad Sci U S A (1994) 0.90
Platelet-derived growth factor stimulation of GTPase-activating protein tyrosine phosphorylation in control and c-H-ras-expressing NIH 3T3 cells correlates with p21ras activation. Mol Cell Biol (1992) 0.88
Neu differentiation factor/heregulin induction by hepatocyte and keratinocyte growth factors. Oncogene (2000) 0.87
Hyperphosphorylation and increased proteolytic breakdown of c-Myb induced by the inhibition of Ser/Thr protein phosphatases. Oncogene (2000) 0.87
A single amino acid substitution is sufficient to modify the mitogenic properties of the epidermal growth factor receptor to resemble that of gp185erbB-2. EMBO J (1992) 0.87
Hepatocyte growth factor induction of collagenase 3 production in human osteoarthritic cartilage: involvement of the stress-activated protein kinase/c-Jun N-terminal kinase pathway and a sensitive p38 mitogen-activated protein kinase inhibitor cascade. Arthritis Rheum (2001) 0.85
A cell-permeable peptide inhibits activation of PKR and enhances cell proliferation. Peptides (2000) 0.85
Induction of tissue inhibitor of metalloproteinases-3 is a delayed early cellular response to hepatocyte growth factor. Oncogene (1998) 0.84
Ligand-independent activation of fibroblast growth factor receptor-2 by carboxyl terminal alterations. Oncogene (1997) 0.83
A novel human ERK phosphatase regulates H-ras and v-raf signal transduction. Oncogene (1997) 0.82
Human dual specificity phosphatase VHR activates maturation promotion factor and triggers meiotic maturation in Xenopus oocytes. J Biol Chem (1995) 0.81
Peptides derived from the interferon-induced PKR prevent activation by HIV-1 TAR RNA. Virology (1996) 0.80
Colocalization of heparin and receptor binding sites on keratinocyte growth factor. Biochemistry (1998) 0.80
Heparan sulfate proteoglycan modulates keratinocyte growth factor signaling through interaction with both ligand and receptor. Biochemistry (1999) 0.80
The 18 kDa cytosolic acid phosphatase from bovine live has phosphotyrosine phosphatase activity on the autophosphorylated epidermal growth factor receptor. FEBS Lett (1989) 0.78
Nursing assessment and intervention for adult hemodialysis patients: application of Roy's Adaptation Model. ANNA J (1998) 0.77
Platelet contribution to cancer cell growth and migration: the role of platelet growth factors. Haemostasis (1988) 0.77
Human FRAG1 encodes a novel membrane-spanning protein that localizes to chromosome 11p15.5, a region of frequent loss of heterozygosity in cancer. Genomics (1999) 0.76
The acidic domain and first immunoglobulin-like loop of fibroblast growth factor receptor 2 modulate downstream signaling through glycosaminoglycan modification. Mol Cell Biol (1999) 0.75
Images of nephrology nursing practice: report of a survey. ANNA J (1992) 0.75
Behavioural and biochemical studies on 6-methylamino-4,5,6,7-tetrahydrobenzothiazole (14.839JL), a new potent dopaminergic agonist. Pharmacol Res Commun (1987) 0.75